NCT04995536: CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL |
|
|
| Withdrawn | 1 | 18 | NA | CpG-STAT3 siRNA CAS3/SS3, CAS3/SS3, CpG ODN/STAT3 siRNA CAS3/SS3, CpG Oligodeoxynucleotide/STAT3 siRNA CAS3/SS3, CpG/Anti-STAT3 siRNA CAS3/SS3, CpG/STAT3 siRNA CAS3/SS3, TLR9 Agonist/STAT3 siRNA Conjugate CAS3/SS3, Radiation Therapy, Cancer Radiotherapy, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation | City of Hope Medical Center, National Cancer Institute (NCI) | Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Grade 3a Follicular Lymphoma, Recurrent Grade 3b Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Grade 1 Follicular Lymphoma, Refractory Grade 2 Follicular Lymphoma, Refractory Grade 3 Follicular Lymphoma, Refractory Grade 3a Follicular Lymphoma, Refractory Mantle Cell Lymphoma, Refractory Marginal Zone Lymphoma, Refractory Small Lymphocytic Lymphoma, Refractory Grade 3b Follicular Lymphoma | 01/24 | 01/24 | | |
